1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005
2. Diagnosis, management, and treatment of hepatitis C;Strader;HEPATOLOGY,2004
3. First report on the antiviral efficacy of BILN 2061, a novel oral serine protease inhibitor, in patients with chronic hepatitis C genotype 1 [Abstract];Hinrichsen;HEPATOLOGY,2002
4. Boceprevir (BOC) combined with peginterferon alfa-2b/ribavirin (P/R) for treatment-naïve patients with hepatitis C virus (HCV) genotype (G) 1: SPRINT-2 final results [Abstract];Poordad;HEPATOLOGY,2010
5. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial;Kwo;Lancet